Brind.

Truist Financial, Morgan Stanley, and Citigroup issued analyst ratings and price targets for Fresenius Medical Care.

7 reports, 3 independent Updated Oct 20
Gone quiet Reached 2 outlets in its first 24 hours
Reports
7
Developments
3
Repetition
57%

New informationRepeats or wire copies

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Well supportedReported by 3 independent outlets

Truist Financial, Morgan Stanley, and Citigroup issued analyst ratings and price targets for Fresenius Medical Care.

Who's involved

What this event is mainly about

How it developed

Newest first. Tap a step to see who reported it.
  1. Truist dropped target price, while BNP Paribas and Berenberg Bank also issued new ratings for FMS.1 source
  2. Berenberg Bank set a price target, while Truist cut its target and Citigroup reissued a neutral rating on Fresenius stock.1 source
  3. Financial firms issued analyst ratings and price targets for Fresenius Medical Care.1 source

Keep exploring

The entities involved

Coverage

Newest first; wire copies grouped
3 more outlets ran the same wire story